1. Home
  2. STOK vs FOXF Comparison

STOK vs FOXF Comparison

Compare STOK & FOXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • FOXF
  • Stock Information
  • Founded
  • STOK 2014
  • FOXF 2007
  • Country
  • STOK United States
  • FOXF United States
  • Employees
  • STOK N/A
  • FOXF N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • FOXF Motor Vehicles
  • Sector
  • STOK Health Care
  • FOXF Consumer Discretionary
  • Exchange
  • STOK Nasdaq
  • FOXF Nasdaq
  • Market Cap
  • STOK 1.3B
  • FOXF 1.2B
  • IPO Year
  • STOK 2019
  • FOXF N/A
  • Fundamental
  • Price
  • STOK $31.97
  • FOXF $25.01
  • Analyst Decision
  • STOK Strong Buy
  • FOXF Buy
  • Analyst Count
  • STOK 7
  • FOXF 6
  • Target Price
  • STOK $30.83
  • FOXF $33.50
  • AVG Volume (30 Days)
  • STOK 1.5M
  • FOXF 471.1K
  • Earning Date
  • STOK 11-12-2025
  • FOXF 11-06-2025
  • Dividend Yield
  • STOK N/A
  • FOXF N/A
  • EPS Growth
  • STOK N/A
  • FOXF N/A
  • EPS
  • STOK 0.91
  • FOXF N/A
  • Revenue
  • STOK $199,893,000.00
  • FOXF $1,441,852,000.00
  • Revenue This Year
  • STOK $416.54
  • FOXF $8.61
  • Revenue Next Year
  • STOK N/A
  • FOXF $5.55
  • P/E Ratio
  • STOK $35.55
  • FOXF N/A
  • Revenue Growth
  • STOK 1218.82
  • FOXF 7.16
  • 52 Week Low
  • STOK $5.35
  • FOXF $17.95
  • 52 Week High
  • STOK $38.69
  • FOXF $38.36
  • Technical
  • Relative Strength Index (RSI)
  • STOK 62.96
  • FOXF 54.28
  • Support Level
  • STOK $31.19
  • FOXF $22.28
  • Resistance Level
  • STOK $34.86
  • FOXF $24.00
  • Average True Range (ATR)
  • STOK 2.77
  • FOXF 0.85
  • MACD
  • STOK -0.28
  • FOXF 0.31
  • Stochastic Oscillator
  • STOK 46.19
  • FOXF 88.99

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.

Share on Social Networks: